CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Lizzo reveals her disciplined meal plan and lifestyle changes that led to a 16% body fat reduction, sharing insights on health and wellness.

Patients frequently come to Leslie Golden, MD, with questions about supplements for weight loss. “I’d say nearly every patient has tried or considered supplements at some point before they get ...

Trend alert! Split dosing, stretch dosing, skip dosing, microdosing Ozempic… People are finding creative ways to use ...

Intermittent fasting resulted in similar weight loss as traditional calorie restriction, according to a new review. Experts say that the similar results across different diet protocols mean ...

Weight-loss surgery was shown to be five times more effective than weekly injections of popular GLP-1 receptor agonists, including semaglutide (such as Ozempic) and tirzepatide (such as Mounjaro).

Why weight loss can be so hard with thyroid issues — and what actually works TOI Lifestyle Desk / etimes.in / Jun 10, 2025, 13:02 IST ...

A recent study done in the U.S. showed that semaglutide and tirzepatide — injectable GLP-1 drugs for obesity — produce lower weight loss in a real-world setting, than during the clinical trial ...

Many people also experience rapid weight loss on these drugs, which can lead to the loss of lean muscle. Discuss possible side effects with your doctor to decide which option may be best for you.

Middlesex County Popular ‘miracle’ weight loss drug is causing people to lose their vision, lawsuits claim Published: Jun. 19, 2025, 11:00 a.m.

Weight loss drugs like semaglutide could add £4.5 billion to the UK economy annually, boosting productivity and reducing alcohol use, though high costs may limit broad access.